(1) Subject to subsection (3) and section 15, the National Competent Authority shall consider an application for the conduct of a clinical trial and grant, or refuse to grant, an authorization within 30 days from the date of receipt of the application for authorization of a clinical trial.
(2) Upon receipt of an application, the National Competent Authority may give notice in writing to the applicant requesting him or her to provide further information relating to the particulars referred to in section 13(2)(b)(i).
(3) Where the National Competent Authority gives a notice under subsection (2), the period specified in subsection (1) is suspended from the date the notice is given and recommences on receipt of the information requested.